Financials in USD. Standardized financial statements.
A compact view of how G Medical Innovations Holdings Ltd turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.42M | $4.96M | $4.90M | $3.89M | $2.37M | $83,956 | $0 | $0 |
| Revenue Growth? | -10.9% | +1.2% | +26.1% | +64.1% | +2720.3% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $3.64M | $3.45M | $4.23M | $4.04M | $3.12M | $889,631 | $17,000 | $9,000 |
| Gross Profit? | $784,000 | $1.51M | $667,000 | -$156,839 | -$749,307 | -$805,675 | -$17,000 | -$9,000 |
| Gross Margin? | +17.7% | +30.4% | +13.6% | -4.0% | -31.6% | -959.6% | 0.0% | 0.0% |
| Operating Expenses? | $22.90M | $12.48M | $12.97M | $8.83M | $12.54M | $19.62M | $2.65M | $1.92M |
| Operating Income? | -$22.11M | -$10.97M | -$12.30M | -$8.99M | -$13.29M | -$20.43M | -$2.66M | -$1.93M |
| EBITDA? | -$8.65M | -$8.74M | -$10.54M | -$6.78M | -$14.09M | -$20.04M | -$2.65M | -$1.92M |
| Income Before Tax | -$13.94M | -$14.59M | -$12.71M | -$11.51M | -$13.39M | -$20.92M | -$2.99M | -$1.96M |
| Income Tax Expense | $16,000 | -$3,000 | -$18,000 | -$602,743 | -$266,781 | $65,470 | $30,000 | $29,000 |
| Net Income? | -$24.63M | -$14.76M | -$12.54M | -$10.91M | -$13.13M | -$20.84M | -$3.02M | -$1.99M |
| EPS? | $-34.17 | $-45.49 | $-59.67 | $-4.92 | $-6.77 | $-15.50 | $-2.25 | $-1.48 |
| Diluted EPS? | $-34.17 | $-45.49 | $-59.67 | $-4.92 | $-6.77 | $-15.50 | $-2.25 | $-1.48 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality